AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΊπ¬
PARACETAMOL + PHENYLEPHRINE HYDROCHLORIDE + CHLORPHENAMINE MALEATE in Uganda
8 products registered with NDA β 8 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| PARACETAMOL +
PHENYLEPHRINE
HYDROCHLORIDE +
CHLORPHENAMINE
MALEATE ORAL SOLID
ORDINARY
TABLETS | UNKNOWN-21282d75 | WALLACE PHARMACEUTICA LS PVT. LTD | active | β |
| PARACETAMOL +
PHENYLEPHRINE
HYDROCHLORIDE +
CHLORPHENAMINE
MALEATE ORAL SOLID
ORDINARY
TABLETS | UNKNOWN-fdcab711 | EXPHAR SA. | active | β |
| PARACETAMOL +
PHENYLEPHRINE
HYDROCHLORIDE +
CHLORPHENAMINE
MALEATE ORAL SOLID
ORDINARY TABLETS | UNKNOWN-3c6bea1f | WALLACE PHARMACEUTICA LS PVT. LTD | active | β |
| PARACETAMOL +
PHENYLEPHRINE
HYDROCHLORIDE +
CHLORPHENAMINE
MALEATE ORAL SOLID
ORDINARY TABLETS | UNKNOWN-9364fb05 | WALLACE PHARMACEUTICA LS PVT. LTD | active | β |
| PARACETAMOL +
PHENYLEPHRINE
HYDROCHLORIDE +
CHLORPHENAMINE
MALEATE ORAL SOLID
ORDINARY TABLETS | UNKNOWN-d10951d6 | EXPHAR SA. | active | β |
| PARACETAMOL +
PHENYLEPHRINE
HYDROCHLORIDE +
CHLORPHENAMINE
MALEATE ORAL SOLID
ORDINARY
TABLETS | UNKNOWN-49a91023 | EXPHAR SA. | active | β |
| PARACETAMOL +
PHENYLEPHRINE
HYDROCHLORIDE +
CHLORPHENAMINE
MALEATE ORAL SOLID
ORDINARY TABLETS | UNKNOWN-23ca2c02 | EXPHAR SA. | active | β |
| PARACETAMOL +
PHENYLEPHRINE
HYDROCHLORIDE +
CHLORPHENAMINE
MALEATE ORAL SOLID
ORDINARY
TABLETS | UNKNOWN-bef90ae1 | WALLACE PHARMACEUTICA LS PVT. LTD | active | β |
PARACETAMOL + PHENYLEPHRINE HYDROCHLORIDE + CHLORPHENAMINE MALEATE β NDA Registration Details
NDA (Uganda) has 8 registered products containing PARACETAMOL + PHENYLEPHRINE HYDROCHLORIDE + CHLORPHENAMINE MALEATE, of which 8 are currently active. Data is sourced directly from the official NDA drug register and refreshed daily.
Track PARACETAMOL + PHENYLEPHRINE HYDROCHLORIDE + CHLORPHENAMINE MALEATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.